SCHEMBL22950927

SCHEMBL22950927

COc1cc(N2CCN3CCCCC3C2)c(-c2cnn(C)c2)cc1Nc1ncc(Cl)c(Nc2ccc(C)c(C)c2P(C)(C)=O)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 13/20 0.64
▸ BTK Q06187 2/20 0.59
▸ INSR P06213 7/20 0.53
▸ IGF1R P08069 7/20 0.53
▸ ALK Q9UM73 7/20 0.53
▸ LRRK2 Q5S007 2/20 0.47
▸ CHEK1 O14757 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ NUAK1 O60285 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ STK10 O94804 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ SLC34A2 O95436 1/20 0.47
▸ CHEK2 O96017 1/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ CD74 P04233 1/20 0.47
▸ ERBB2 P04626 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ FES P07332 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22950925 1.00 EGFR (0.64) EGFRBTKINSRIGF1RALK
SCHEMBL22950900 0.92 EGFR (0.73) EGFRBTKINSRIGF1RALK
SCHEMBL22950965 0.90 EGFR (0.62) EGFRBTKINSRIGF1RALK
SCHEMBL22942153 0.89 EGFR (0.59) EGFRBTKINSRIGF1RALK
SCHEMBL22950967 0.88 EGFR (0.59) EGFRBTKCHEK1AURKAJAK2
SCHEMBL28775789 0.86 EGFR (0.67) EGFRBTKINSRIGF1RALK
SCHEMBL22950973 0.86 EGFR (0.79) EGFRBTKINSRIGF1RALK
SCHEMBL28529517 0.85 EGFR (0.59) EGFR
SCHEMBL22950986 0.84 EGFR (0.61) EGFRBTKCHEK1AURKAJAK2
SCHEMBL29558563 0.84 EGFR (0.61) EGFRBTKCHEK1AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114430739-A EGFR inhibitor, composition and preparation method thereof 贝达药业股份有限公司 2022-05-03 — — CN disclosed
WO-2021018009-A1 EGFR INHIBITOR, COMPOSITION, AND PREPARATION METHOD THEREFOR 贝达药业股份有限公司 2021-02-04 — — WO disclosed
Send feedback